Combating Oestrogen Deficiency in Vulvovaginal Atrophy

Combating Oestrogen Deficiency in Vulvovaginal Atrophy

Vulvovaginal atrophy and dryness are common symptoms of the
decline in endogenous production of oestrogen at menopause and
often result in dyspareunia. The main goals of treatment for vaginal
atrophy are to improve symptoms and to restore vaginal and vulvar
anatomic changes. Treatment choices for postmenopausal
dyspareunia resulting from vulvovaginal atrophy will depend on
the underlying aetiology and might include individualised treatment.

Modern Medicine – August 2017

Verified by ExactMetrics